Tekturna Linked to Serious and Life-Threatening Side Effects
The widely prescribed blood pressure medication, Tekturna® has been linked to reports of dangerous and life-threatening side effects including:
- Sudden death
- Renal complications
- Low blood pressure
- Heart attack
The risk of adverse effects with Tekturna increase when used in combination with other heart medications including ACE inhibitors or ARBs. Tekturna lawsuits are expected to ensue based on these findings.
Pursue a Tekturna Lawsuit
You may want to pursue a Tekturna lawsuit if you are taking this medication and have experienced adverse side effects. Novartis, the maker of Tekturna, terminated a clinical trial with the drug when reports showed high rates of adverse events occurring in combination with other blood pressure medications. Specifically, there was an increased rate of stroke, renal complications, hyperkalemia and low blood pressure in patients 18 to 24 months after taking the drug.
FDA Warns Against Tekturna
The Food and Drug Administration (FDA) approved Tekturna in 2007. In 2011, Novartis began adding warning labels to the drug in the U.S., Europe, and Canada after reports showed high rates of adverse events. In April of 2012, the FDA added a warning against the use of Tekturna when taken in combination with ACE inhibitors and ARBs in patients with diabetes or kidney impairment. The FDA has not yet officially linked these drugs to death and stroke.
Is a Tekturna lawsuit right for you? If you are taking Tekturna and have been injured, you may be able to pursue a Tekturna lawsuit. Contact Sokolove Law for a free legal consultation and to find out if a Tekturna lawsuit may be an option for you.